MG
MTEM

Michael Gelband’s Molecular Templates, Inc. MTEM Stock Holding History

Michael Gelband’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,018
Closed -$119K – 2822
2021
Q2 		$119K Sell
1,018
-249
-20% -$32.6K ﹤0.01% 2115
2021
Q1 		$240K Buy
+1,267
New +$222K ﹤0.01% 1791
2020
Q3 		– Sell
-1,506
Closed -$311K – 2354
2020
Q2 		$311K Buy
+1,506
New +$350K 0.01% 1303

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Michael Gelband's MTEM Position: Q3 2021 in Review

Michael Gelband sold out of Molecular Templates, Inc. (MTEM) in Q3 2021, closing a stake of 1,018 shares — an estimated $119K sold.

Michael Gelband first reported a position in MTEM in Q2 2020 and held it in 3 quarters. The position peaked at $311K in Q2 2020. 86 funds tracked by Wall St. Rank hold MTEM as of Q3 2021.

  • Michael Gelband reported no remaining Molecular Templates, Inc. position as of Q3 2021 after selling out during the quarter.
  • Michael Gelband sold 1,018 Molecular Templates, Inc. shares in Q3 2021, an estimated $119K.
  • Michael Gelband first reported a position in Molecular Templates, Inc. in Q2 2020 and held it in 3 quarters.
  • Michael Gelband's Molecular Templates, Inc. position peaked at $311K in Q2 2020.
  • 86 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.